// App-Quantinova.ai

2599 : A Novel PF4-Dependent P-Selectin Expression Assay (PEA) Facilitates Earlya Detection of Pathogenic HIT Antibodies: Implications for Diagnosis and Treatment of HIT

Researchers

Presenter

  • Anand Padmanabhan

Principal Investigators

  • Curtis G Jones

  • Shannon M Pechauer

  • Brian R Curtis

  • Daniel W. Bougie

  • Mia J Sullivan

  • Mehraboon S. Irani

  • Binod Dhakal

  • Lisa M. Baumann Kreuziger

  • Brenda M. Pierce

  • Richard H. Aster

Medical Centers

  • Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

  • Blood Center of Wisconsin, Milwaukee, WI

  • Medical Sciences Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Blood Center of Wisconsin, Milwaukee, WI

  • Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI

  • Blood Research Institute and Platelet & Neutrophil Immunology Laboratory, Blood Center of Wisconsin and Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

  • Aurora, Franklin, WI

  • Medical College of Wisconsin, Blood Center of Wisconsin, Milwaukee, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Thrombocytopenia

Biomarkers

  • P-selectin

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved